Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Screening for non-motor symptoms in Parkinson's disease using the NMSQuest scale

https://doi.org/10.14412/2074-2711-2017-3-42-47

Full Text:

Abstract

The clinical picture of Parkinson's disease (PD) includes a wide range of non-motor symptoms (NMS) that substantially worsen quality of life in patients. These symptoms are poorly diagnosed because they are not emphasized by patients themselves and their relatives. The low detectability of NMS can be attributable to the lack of awareness amongst specialists about a wide range of PD symptoms and to that of time at a visit for physician advice.
Objective: to evaluate the effectiveness of using the screening scale to timely detect NMS in PD.
Patients and methods. Examinations were made in 2 patient groups: 1) 95 PD patients aged 47 to 83 years (mean age, 64.91±7.66 years) (a study group); 2) 37 sex- and age-matched healthy individuals aged 48 to 77 years (mean age, 62.22±6.58 years) without signs of PD and PD of another etiology (a control group). To identify NMS, all the study participants filled out the NMSQuest scale.
Results. The mean number of NMS per patient with PD was 9.13±4.81 in the study group and 5.43±3.4 in the control group (p<0.001).
Symptoms, such as hypersalivation, hyposmia, dysphagia, nausea, vomiting, constipation, excessive sweating, decreased motivation, and a feeling of sadness, were statistically significantly more common in PD. There were no significant differences between the number of NMSs and the form of PD or convincing data on their relationship to age, disease stage, and the total equivalent dose of taken antiparkinsonian drugs (calculated with reference to levodopa).
Conclusion. The use of questionnaires in patients with PD allows the timely detection of the majority of NMSs. Given the limited time for counseling the patient, especially at an outpatient stage, the questionnaires should be filled out by the patient while he/she is waiting for a doctor's consultation.

About the Authors

A. A. Tappakhov
M.K. Ammosov North-Eastern Federal University
Russian Federation
58, Belinsky St., Yakutsk, 677000, Russia;


T. E. Popova
M.K. Ammosov North-Eastern Federal University
Russian Federation
58, Belinsky St., Yakutsk, 677000, Russia;


T. Ya. Nikolaeva
M.K. Ammosov North-Eastern Federal University
Russian Federation
58, Belinsky St., Yakutsk, 677000, Russia;


N. A. Schnaider
Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
Russian Federation
1, Partisan Zheleznyak St., Krasnoyarsk 660022, Russia


M. M. Petrova
Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
Russian Federation
1, Partisan Zheleznyak St., Krasnoyarsk 660022, Russia


References

1. Aron L, Klein R. Repairing the parkinsonian brain with neurotrophic factors. Trends Neurosci. 2011;34(2):88-100. doi:10.1016/j.tins.2010.11.001.

2. Baumann CR. Epidemiology, diagnosis and differential diagnosis in Parkinson’s disease tremor. Parkinsonism Relat Disord. 2012;18 Suppl 1:S90-2. doi:10.1016/S1353-8020 (11)70029-3.

3. Berardelli A, Wenning GK, Antonini A, et al. EFNS/MDS-ES recommendations for the diagnosis of Parkinson’s disease. Eur J Neurol. 2013 Jan;20(1):16-34. doi:10.1111/ene.12022.

4. Lim SY, Lang AE. The nonmotor symptoms of Parkinson’s disease--an overview. Mov Disord. 2010;25 Suppl 1:S123-30. doi:10.1002/mds.22786.

5. Braak H, Ghebremedhin E, Rü b U, et al. Stages in the development of Parkinson’s disease-related pathology. Cell Tissue Res. 2004 Oct;318(1):121-34. Epub 2004 Aug 24.

6. Rietdijk CD, Perez-Pardo P, Garssen J. Exploring Braak’s Hypothesis of Parkinson’s Disease. Front Neurol. 2017 Feb 13;8:37. doi: 10.3389/fneur.2017.00037. eCollection 2017.

7. Schrag A, Horsfall L, Walters K, et al. Prediagnostic presentations of Parkinson’s disease in primary care: A case-control study. Lancet Neurol. 2015;14(1):57-64. doi:10.1016/S1474-4422(14)70287-X.

8. Gallagher DA, Lees AJ, Schrag A. What are the most important nonmotor symptoms in patients with Parkinson’s disease and are we missing them? Mov Disord. 2010 Nov 15; 25(15):2493-500. doi: 10.1002/mds.23394.

9. Chaudhuri KR, Schapira AH. Non-motor symptoms of Parkinson’s disease: dopaminergic pathophysiology and treatment. Lancet Neurol. 2009;8(5):464-74. doi:10.1016/S1474-4422(09)70068-7.

10. Shulman LM, Taback RL, Rabinstein AA, Weiner WJ. Non-recognition of depression and other non-motor symptoms in Parkinson’s disease. Parkinsonism Relat Disord. 2002;8(3):193-7.

11. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry. 1988 Jun;51(6):745-52. doi:10.1136/jnnp.51.6.745.

12. Chaudhuri KR, Martinez-Martin P, Schapira AH, et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson’s disease: the NMSQuest study. Mov Disord. 2006;21(7):916-923. doi:10.1002/mds.20844.

13. Нодель МР. Влияние нервно-психических нарушений на качество жизни пациентов с болезнью Паркинсона. Неврологический журнал. 2015;20(1):20–7. [Nodel MR. The impact of neuropsychiatric symptoms on quality of life of patients with Parkinson’s disease. Nevrologicheskii zhurnal. 2015;20(1):20-7. (In Russ.)]. doi:10.18821/1560-9545-2015-20-1-20-27.

14. Яхно НН, Нодель МР. Особенности депрессии при болезни Паркинсона. Доктор.ру. 2013;(5):50-4. [Yakhno NN, Nodel MR. Features of depresstion in Parkinson's disease. Doktor.ru. 2013;(5);50-4. (In Russ.)].

15. Dissanayaka NN, White E, O’Sullivan JD, et al. The clinical spectrum of anxiety in Parkinson’s disease. Mov Disord. 2014 Jul; 29(8):967-75. doi: 10.1002/mds.25937.

16. Kalbe E, Rehberg SP, Heber I, et al. Subtypes of mild cognitive impairment in patients with Parkinson’s disease: evidence from the LANDSCAPE study. J Neurol Neurosurg Psychiatry. 2016;87(10):1099-105. doi:10.1136/jnnp-2016-313838.

17. Levin J, Hasan A, Hö glinger GU. Psychosis in Parkinson’s disease: identification, prevention and treatment. J Neural Transm. 2016; 123(1):45-50. doi:10.1007/s00702-015-1400-x.

18. Adler CH, Thorpy MJ. Sleep issues in Parkinson’s disease. Neurology. 2005; 64(12 Suppl 3):S12-20.

19. Ylikoski A, Martikainen K, Sieminski M, Partinen M. Parkinson’s disease and insomnia. Neurol Sci. 2015;36(11):2003-10. doi:10.1007/s10072-015-2288-9.

20. Romenets SR, Gagnon JF, Latreille V, et al. Rapid eye movement sleep behavior disorder and subtypes of Parkinson’s disease. Mov Disord. 2012;27(8):996-1003. doi:10.1002/mds.25086.

21. Ляшенко ЕА, Полуэктов МГ, Левин ОС. Нарушения поведения во сне с быстрыми движениями глаз у пациентов с болезнью Паркинсона. В кн.: Иллариаошкин СН, Левин ОС, редакторы. Болезнь Паркинсона и расстройства движений: руководство для врачей по материалам III Национального конгресса. Москва: РКИ Соверо пресс; 2014. С. 114–5. [Lyashenko EA, Poluektov MG, Levin OS. Behavioral disturbances in REM-sleep in patients with Parkinson's disease. In: Illariaoshkin SN, Levin OS, editors. Bolezn' Parkinsona i rasstroistva dvizhenii: rukovodstvo dlya vrachei po materialam III Natsional'nogo kongressa [Parkinson's disease and movement disorders: a guidelines based on the materials of the 3th National Congress]. Moscow: RKI Severo press; 2014. P. 114-5].

22. Knie B, Mitra MT, Logishetty K, Chaudhuri KR. Excessive daytime sleepiness in patients with Parkinson’s disease. CNS Drugs. 2011;25(3):203-12. doi:10.2165/11539720-000000000-00000.


For citation:


Tappakhov A.A., Popova T.E., Nikolaeva T.Y., Schnaider N.A., Petrova M.M. Screening for non-motor symptoms in Parkinson's disease using the NMSQuest scale. Neurology, Neuropsychiatry, Psychosomatics. 2017;9(3):42-47. (In Russ.) https://doi.org/10.14412/2074-2711-2017-3-42-47

Views: 283


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)